At Paidagene Solutions, we design and develop advanced non-viral delivery systems, specifically lipid and polymer nanoparticles, for gene and cell therapy applications.

Our platforms enable the safe, efficient, and targeted delivery of genetic materials, including mRNA, siRNA, and gene-editing tools, to specific tissues and immune cells.

We aim to transform patient care by making genetic therapies more accessible, precise, and effective. By overcoming the limitations of traditional viral vectors, we strive to deliver treatments that reach underserved populations, tackle complex diseases, and improve long-term outcomes for patients.

We invite researchers, healthcare innovators, biotech firms, and mission-driven investors to join us on this journey. Together, we can accelerate the development of next-generation therapies and create a healthier future through smarter, safer gene delivery technologies.